Hillstream Biopharma Stock Market Capitalization
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
Hillstream Biopharma fundamentals help investors to digest information that contributes to Hillstream Biopharma's financial success or failures. It also enables traders to predict the movement of Hillstream Stock. The fundamental analysis module provides a way to measure Hillstream Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hillstream Biopharma stock.
Hillstream |
Hillstream Biopharma Company Market Capitalization Analysis
Hillstream Biopharma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Hillstream Biopharma Market Capitalization | 4.23 M |
Most of Hillstream Biopharma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hillstream Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Hillstream Biopharma is about 4.23 M. This is 99.97% lower than that of the Biotechnology sector and 99.91% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.98% higher than that of the company.
Hillstream Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hillstream Biopharma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics of similar companies.Hillstream Biopharma is currently under evaluation in market capitalization category among its peers.
Hillstream Fundamentals
| Return On Equity | -1.47 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 496.66 K | |||
| Shares Outstanding | 17.53 M | |||
| Shares Owned By Insiders | 38.90 % | |||
| Shares Owned By Institutions | 0.80 % | |||
| Number Of Shares Shorted | 52.74 K | |||
| Price To Book | 0.88 X | |||
| EBITDA | (6.88 M) | |||
| Net Income | (8.47 M) | |||
| Cash And Equivalents | 9.48 M | |||
| Cash Per Share | 0.82 X | |||
| Total Debt | 772.9 K | |||
| Current Ratio | 13.13 X | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (6.56 M) | |||
| Short Ratio | 0.20 X | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 4.0 | |||
| Market Capitalization | 4.23 M | |||
| Total Asset | 6.69 M | |||
| Retained Earnings | (15.38 M) | |||
| Working Capital | 5.54 M | |||
| Z Score | -2.34 | |||
| Net Asset | 6.69 M |
About Hillstream Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |